BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 37232505)

  • 1. Association between genetically determined telomere length and health-related outcomes: A systematic review and meta-analysis of Mendelian randomization studies.
    Chen B; Yan Y; Wang H; Xu J
    Aging Cell; 2023 Jul; 22(7):e13874. PubMed ID: 37232505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the association of leukocyte telomere length with ankylosing spondylitis and rheumatoid arthritis: A bidirectional Mendelian randomization study.
    Wei D; Jiang Y; Cheng J; Wang H; Sha K; Zhao J
    Front Immunol; 2023; 14():1023991. PubMed ID: 37033949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study.
    Xia K; Zhang L; Zhang G; Wang Y; Huang T; Fan D
    Orphanet J Rare Dis; 2021 Dec; 16(1):508. PubMed ID: 34906191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study.
    Liao Q; He J; Tian FF; Bi FF; Huang K
    Front Immunol; 2022; 13():922922. PubMed ID: 35911771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte telomere length and bipolar disorder risk: evidence from Mendelian randomization analysis.
    Lu L; Zeng H; Wan B; Sun M
    PeerJ; 2023; 11():e15129. PubMed ID: 37020849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the causal effects of leukocyte telomere length and four gastrointestinal diseases: a two-sample bidirectional Mendelian randomization study.
    Wang H; Chen X; Wang S; Zhang H
    BMC Gastroenterol; 2023 Dec; 23(1):446. PubMed ID: 38110867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian randomization study on the causal relationship between leukocyte telomere length and prostate cancer.
    Wan B; Lu L; Lv C
    PLoS One; 2023; 18(6):e0286219. PubMed ID: 37352282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between genetically predicted leukocyte telomere length and non-scarring alopecia: A two-sample Mendelian randomization study.
    Li Y; Yang S; Liao M; Zheng Z; Li M; Wei X; Liu M; Yang L
    Front Immunol; 2022; 13():1072573. PubMed ID: 36798520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study.
    Liu M; Luo P; Liu L; Wei X; Bai X; Li J; Wu L; Luo M
    Front Genet; 2023; 14():1129247. PubMed ID: 37139230
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte telomere length is associated with increased risk of endometriosis: a bidirectional two-sample Mendelian randomization study.
    Bai C; Shen Z; Qiu B; Zhang S
    Front Endocrinol (Lausanne); 2023; 14():1272200. PubMed ID: 38034012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between COVID-19 and telomere length: A bidirectional Mendelian randomization study.
    Huang D; Lin S; He J; Wang Q; Zhan Y
    J Med Virol; 2022 Nov; 94(11):5345-5353. PubMed ID: 35854470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Potential Causal Effects of Telomere Length on Health Outcomes: A Phenome-Wide Investigation and Mendelian Randomization Study.
    Wang W; Huang N; Zhuang Z; Song Z; Li Y; Dong X; Xiao W; Zhao Y; Jia J; Liu Z; Qi L; Huang T
    J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37209418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of telomere length with risk of rheumatoid arthritis: a meta-analysis and Mendelian randomization.
    Zeng Z; Zhang W; Qian Y; Huang H; Wu DJH; He Z; Ye D; Mao Y; Wen C
    Rheumatology (Oxford); 2020 May; 59(5):940-947. PubMed ID: 31697380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for causality between systematically identified risk factors and glioma: a Mendelian randomization study.
    Howell AE; Robinson JW; Wootton RE; McAleenan A; Tsavachidis S; Ostrom QT; Bondy M; Armstrong G; Relton C; Haycock P; Martin RM; Zheng J; Kurian KM
    BMC Cancer; 2020 Jun; 20(1):508. PubMed ID: 32493226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying effects of genetic obesity exposure on leukocyte telomere length using Mendelian randomization.
    Wan B; Ma N; Lv C
    PeerJ; 2023; 11():e15085. PubMed ID: 36967999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length and metabolic syndrome traits: A Mendelian randomisation study.
    Loh NY; Noordam R; Christodoulides C
    Aging Cell; 2021 Aug; 20(8):e13445. PubMed ID: 34312982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Causal Relationships between Leukocyte Telomere Length, Sex Hormone-Binding Globulin Levels, and Osteoporosis Using Univariable and Multivariable Mendelian Randomization.
    Sun K; Li M; Wu Y; Wu Y; Zeng Y; Zhou S; Peng L; Shen B
    Orthop Surg; 2024 Feb; 16(2):320-328. PubMed ID: 38084376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian randomization and colocalization analyses reveal an association between short sleep duration or morning chronotype and altered leukocyte telomere length.
    Hu J; Lu J; Lu Q; Weng W; Guan Z; Wang Z
    Commun Biol; 2023 Oct; 6(1):1014. PubMed ID: 37803147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instant Coffee Is Negatively Associated with Telomere Length: Finding from Observational and Mendelian Randomization Analyses of UK Biobank.
    Wei Y; Li Z; Lai H; Lu P; Zhang B; Song L; Zhang L; Shen M
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
    ; Haycock PC; Burgess S; Nounu A; Zheng J; Okoli GN; Bowden J; Wade KH; Timpson NJ; Evans DM; Willeit P; Aviv A; Gaunt TR; Hemani G; Mangino M; Ellis HP; Kurian KM; Pooley KA; Eeles RA; Lee JE; Fang S; Chen WV; Law MH; Bowdler LM; Iles MM; Yang Q; Worrall BB; Markus HS; Hung RJ; Amos CI; Spurdle AB; Thompson DJ; O'Mara TA; Wolpin B; Amundadottir L; Stolzenberg-Solomon R; Trichopoulou A; Onland-Moret NC; Lund E; Duell EJ; Canzian F; Severi G; Overvad K; Gunter MJ; Tumino R; Svenson U; van Rij A; Baas AF; Bown MJ; Samani NJ; van t'Hof FNG; Tromp G; Jones GT; Kuivaniemi H; Elmore JR; Johansson M; Mckay J; Scelo G; Carreras-Torres R; Gaborieau V; Brennan P; Bracci PM; Neale RE; Olson SH; Gallinger S; Li D; Petersen GM; Risch HA; Klein AP; Han J; Abnet CC; Freedman ND; Taylor PR; Maris JM; Aben KK; Kiemeney LA; Vermeulen SH; Wiencke JK; Walsh KM; Wrensch M; Rice T; Turnbull C; Litchfield K; Paternoster L; Standl M; Abecasis GR; SanGiovanni JP; Li Y; Mijatovic V; Sapkota Y; Low SK; Zondervan KT; Montgomery GW; Nyholt DR; van Heel DA; Hunt K; Arking DE; Ashar FN; Sotoodehnia N; Woo D; Rosand J; Comeau ME; Brown WM; Silverman EK; Hokanson JE; Cho MH; Hui J; Ferreira MA; Thompson PJ; Morrison AC; Felix JF; Smith NL; Christiano AM; Petukhova L; Betz RC; Fan X; Zhang X; Zhu C; Langefeld CD; Thompson SD; Wang F; Lin X; Schwartz DA; Fingerlin T; Rotter JI; Cotch MF; Jensen RA; Munz M; Dommisch H; Schaefer AS; Han F; Ollila HM; Hillary RP; Albagha O; Ralston SH; Zeng C; Zheng W; Shu XO; Reis A; Uebe S; Hüffmeier U; Kawamura Y; Otowa T; Sasaki T; Hibberd ML; Davila S; Xie G; Siminovitch K; Bei JX; Zeng YX; Försti A; Chen B; Landi S; Franke A; Fischer A; Ellinghaus D; Flores C; Noth I; Ma SF; Foo JN; Liu J; Kim JW; Cox DG; Delattre O; Mirabeau O; Skibola CF; Tang CS; Garcia-Barcelo M; Chang KP; Su WH; Chang YS; Martin NG; Gordon S; Wade TD; Lee C; Kubo M; Cha PC; Nakamura Y; Levy D; Kimura M; Hwang SJ; Hunt S; Spector T; Soranzo N; Manichaikul AW; Barr RG; Kahali B; Speliotes E; Yerges-Armstrong LM; Cheng CY; Jonas JB; Wong TY; Fogh I; Lin K; Powell JF; Rice K; Relton CL; Martin RM; Davey Smith G
    JAMA Oncol; 2017 May; 3(5):636-651. PubMed ID: 28241208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.